| 24-May-13 12:09PM | Lessons from the best commencement speakers at Fortune |
| 12:03PM | In denial: Corporate America's blindness to gender discrimination at Fortune |
| 10:05AM | Merck & Co Inc Stock Buy Recommendation Reiterated (MRK) at TheStreet |
| 09:02AM | Stocks to Watch: Abercrombie, Infloblox, Pandora at The Wall Street Journal |
| 23-May-13 09:06PM | Boy Scouts of America votes to end century-old ban on gay scouts at Reuters |
| 08:05PM | Merck Insomnia Drug Safe Only in Low Doses at Bloomberg |
| 06:33PM | Unclear Future for Merck's Insomnia Drug at Motley Fool |
| 05:34PM | Merck halts development of experimental Parkinson's drug at Reuters |
| 05:31PM | Merck ends development of Parkinson's disease drug AP |
| 05:01PM | InPlay: Merck provides update on Phase 3 clinical program for preladenant, co's invetigational Parkinson's disease medicine: initial review of data from three separate trials did not provide evidence of efficacy for preladenant Briefing.com |
| 05:00PM | Merck Provides Update on Phase III Clinical Program for Preladenant, the Companys Investigational Parkinsons Disease Medicine Business Wire |
| 04:34PM | Merck Insomnia Drug Safe Only in Lower Doses, Panel Says at Bloomberg |
| 04:30PM | Dow Today: Merck (MRK) Leads The Day Higher, International Business Machines (IBM) Lags at TheStreet |
| 03:41PM | Why Merck Shares Are Cheap And Could Rise To $60 at Seeking Alpha |
| 01:16PM | Procter & Gamble Launches PantoneLIVE and 2 Other Dow Movers to Watch at Wall St. Cheat Sheet |
| 01:03PM | 5 Stocks Raising The Drugs Industry Higher at TheStreet |
| 11:20AM | Socially Minded Seniors Keep Co-Op Spirit Alive In Cambridge at Forbes |
| 09:55AM | AbbVie Price Boost of Drug Slammed in Studies Criticized at Bloomberg |
| 09:33AM | Merck's Magic Sleeping Pills Wake Up Big Pharma at Bloomberg |
| 09:25AM | New Stock Coverage: Can Johnson & Johnson Be Market's Band-Aid? at Minyanville |
| 07:41AM | Early Movers: HRL, HPQ, TSLA, JCP & More at CNBC |
| 01:28AM | Pfizer takes its shot at a vaccine for evasive superbug Reuters |
| 12:59AM | Pfizer takes its shot at a vaccine for evasive superbug at Reuters |
| 22-May-13 09:00PM | Stocks Fall on Fear That Cheap Money May End Soon at Motley Fool |
| 08:48PM | Merck's insomnia drug moves a step closer to U.S. approval at Reuters |
| 06:53PM | FDA panel says Merck's sleep drug safe, effective at lower dose at Reuters |
| 06:52PM | On The Fly: After Hours Movers at theflyonthewall.com |
| 06:28PM | Merck Statement on FDA Advisory Committee Meeting for Suvorexant Business Wire |
| 06:00PM | [$$] FDA Panel Backs Merck Insomnia Drug at The Wall Street Journal |
| 05:47PM | FDA panel backs experimental Merck insomnia drug AP |
| 05:45PM | Merck Enters into Strategic Deal Zacks |
| 05:38PM | [$$] FDA Panel Backs Merck Insomnia Drug at The Wall Street Journal |
| 05:38PM | Merck Insomnia Drug Is Safe Only in Lower Doses, Panel Says at Bloomberg |
| 05:01PM | Merck & Co Inc (MRK): Today's Featured Drugs Laggard at TheStreet |
| 04:54PM | FDA panel: Merck's insomnia drug effective, safe at low doses at Reuters |
| 04:42PM | FDA panel backs experimental Merck insomnia drug AP |
| 04:08PM | Stocks Tumble Nearly 1% on Fed Tapering Fears at CNBC |
| 03:51PM | 4 Big Drug Companies With Big Juicy Yields at Motley Fool |
| 03:24PM | Stocks Drop 1% as Fed Minutes Hint at Tapering at CNBC |
| 02:10PM | Stocks Fall After Fed Minutes Hint at Tapering at CNBC |
| 01:49PM | Stocks Lose Steam as Techs Turn Lower at CNBC |
| 12:19PM | Pfizer Spins Off Zoetis Stake, CleanTech Lands Huge Contracts, and 3 More Hot Stocks at Wall St. Cheat Sheet |
| 12:18PM | Stocks Jump as Bernanke Eases Tapering Fears at CNBC |
| 12:00PM | Dow Today: Merck (MRK) Higher at TheStreet |
| 11:42AM | [video] Benefiting From the Rotation To Cyclicals at TheStreet |
| 11:06AM | Stocks Pull Back on Bernanke Tapering Comments at CNBC |
| 11:06AM | The 5 Highest-Paying Dividend Stocks in Big Pharma at Motley Fool |
| 10:17AM | Stocks Surge on Dovish Bernanke Comments at CNBC |
| 09:57AM | Bernanke...Pre-Empted by Dudley at CNBC |
| 09:31AM | Stocks Open Higher Ahead of Bernanke Testimony at CNBC |
| 08:43AM | Is Merck a Buy at These Prices? at Wall St. Cheat Sheet |
| 08:34AM | Merck's Novel Immunotherapy Drug Receives 'Breakthrough Therapy Designation' at Seeking Alpha |
| 08:06AM | Early Movers: TGT, LOW, MRK, SPLS & More at CNBC |
| 08:02AM | Today's Market News To Trade On: 5 Stocks Moving On News at Seeking Alpha |
| 07:29AM | [$$] Confusion to the Skeptics at Barrons.com |
| 07:29AM | [$$] Don't Lose Sleep Over Merck's Insomnia Drug at Barrons.com |
| 06:40AM | Stock Market News for May 22, 2013 Zacks |
| 05:33AM | Immune system cancer drugs tipped to be a $35 bln market at Reuters |
| 05:28AM | Pricing A Highly Probable Takeover Of MannKind at Seeking Alpha |
| 02:07AM | Merck signs $5 billion share buyback agreement with Goldman Sachs Reuters |
| 21-May-13 10:33PM | Merck signs $5 billion share buyback agreement with Goldman Sachs Reuters |
| 10:28PM | Merck signs $5 bln share buyback agreement with Goldman Sachs at Reuters |
| 10:09PM | Dow Moves Higher on Fed Remarks, Home Depot Earnings at Motley Fool |
| 08:00PM | Merck Charges Higher to Lead the Dow at Motley Fool |
| 07:36PM | Merck Enters Share Repurchase Agreement With Goldman Sachs at Motley Fool |
| 06:56PM | On The Fly: After Hours Movers at theflyonthewall.com |
| 06:25PM | Radar Movers: Saks Surges 18%, Apple Chats With Congress About Taxes at Wall St. Cheat Sheet |
| 06:18PM | Merck to Buy Back $5 Billion of Its Shares From Goldman at Bloomberg |
| 06:13PM | Todays Best Dow Stock: Merck Goes From Laggard to Leader at Motley Fool |
| 06:01PM | Novartis Ramping Up Alzheimers Pursuit as Rivals Drugs Fail at Bloomberg |
| 05:46PM | Pfizer Stock Checkup for May at Motley Fool |
| 05:42PM | Merck to repurchase $5B in common stock AP |
| 05:23PM | After the close: Merck's mysterious gain; Warner and Actavis stay up at MarketWatch |
| 05:15PM | Today's 3 Best Stocks at Motley Fool |
| 05:00PM | Merck Announces $5 Billion Accelerated Share Repurchase Business Wire |
| 05:00PM | [video] Another Rally, More New Highs at CNBC |
| 04:51PM | After-Hours Buzz: Saks, Intuit, NetApp & More at CNBC |
| 04:37PM | U.S. stocks rise after Fed officials QE signal at MarketWatch |
| 04:07PM | Stocks Climb on Dovish Fed Comments; Bernanke Up Next at CNBC |
| 03:47PM | Merck Rises On Unusually High Volume (MRK) at TheStreet |
| 03:37PM | Stocks Rally on Dovish Fed Comments at CNBC |
| 03:05PM | Roche, Reloaded at Investopedia |
| 02:54PM | Stocks Rally on Dovish Fed Comments; HD Surges 3% at CNBC |
| 02:28PM | The Top 3 Diseases Caused by Stress at Motley Fool |
| 12:00PM | Dow Today: Merck (MRK) Higher at TheStreet |
| 11:45AM | After A Big Rally, Pfizer Might Need Some Rest at Investopedia |
| 10:52AM | Cramer Says Buy Merck, Spirit Airlines, and These 2 Hot Stocks at Wall St. Cheat Sheet |
| 10:46AM | Will the FDA Approve Merck's Insomnia Drug? at Motley Fool |
| 08:52AM | New Asthma Drug Generates Excitement For Patients -- And Its Maker at Forbes |
| 20-May-13 10:00PM | Dow Sputters as Rally Runs Out of Steam at Motley Fool |
| 09:00PM | Cisco Stock Among Dow's Biggest Losers at Motley Fool |
| 07:01PM | UK first in EU to get Merck's new Schmallenberg vaccine at Reuters |
| 06:26PM | Cramer's Watch List Ahead of Big Cancer Conference at CNBC |
| 06:20PM | Dow Slips, Led Lower by Merck Stock at Motley Fool |
| 06:12PM | Big Companies Borrowing Billions at Motley Fool |
| 06:07PM | Business Highlights AP |
| 05:42PM | Big Pharma's Biggest Grudge Match at Motley Fool |
| 04:38PM | U.S. stocks drop, retreating from all-time highs at MarketWatch |
| 04:34PM | Bristol Myers Squibb And The New Wave Of Cancer Drugs at Seeking Alpha |
| 04:10PM | Dividend Stocks Are The New Bonds at Motley Fool |
|
| Merck & Co., Inc. provides various health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products worldwide. It offers human health pharmaceutical products, such as therapeutic and preventive agents for the treatment of human disorders in the areas of cardiovascular, diabetes and obesity, respiratory, women's health and endocrine, inflammatory and infectious diseases, oncology, ophthalmology, and others. The company also provides vaccines, including preventive pediatric, adolescent, and adult vaccines. In addition, it discovers, develops, manufactures, and markets animal health products comprising vaccines, antibiotics, and anti-inflammatory drugs for respiratory diseases, as well as products for the treatment of fertility disorders. Further, the company manufactures and sells over-the-counter products consisting of non-drowsy antihistamines; decongestant-free cold/flu medicine for people with high blood pressure; nasal decongestant spray; and products for occasional constipation and frequent heartburn. Additionally, it offers foot care products, including topical antifungal, and foot and sneaker odor/wetness products; and sun care products, such as sun care lotions, sprays, and dry oils. The company serves drug wholesalers and retailers, hospitals, government agencies, physicians, physician distributors, veterinarians, animal producers, food chain and mass merchandiser outlets, club stores, and specialty channels, as well as managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions. It has a collaboration with Sanofi Pasteur S.A. and Abide Therapeutics, Inc.; and has a collaboration and license agreement with Luminex Corporation. The company was founded in 1891 and is headquartered in Whitehouse Station, New Jersey. |
